We have been featured in Forbes twice, GEN, GenomeWeb and MedWatch. Our investors include Biogen founders, Impact Investors such as Investor Circle, the largest impact investment angel groups in the world, Pipeline Angels and a family office; Centurion Holding in New York.

 

We are a Springboard alum company and among the 500 women-owned technology companies they have supported. Genomic Expression came in #2 in the Women’s Founders Pitch event in LA, was in the top 10 companies to pitch for Sir Richard Branson (Virgin Airlines) Extreme Tech Challenge, and invited to dinner with Branson on Necker’s Island, selected into the top 5 diagnostic companies at the Molecular Tri-Conference, finalist in Top 100 Red Herring and top 50 Global Medtech innovator.

 

COVID19 is an RNA virus and we decided to participate in providing solutions and pivoted into COVID19 testing first by validating our own PCR test securing supply chain and filing our own EUA with the FDA and then by invented new chemistry that enables massive scaling of COVID19 testing using existing sequencing lab equipment. That landed us into the semi-finals of the XPRIZE for Rapid COVID19 testing and Blue Cross Blue Shields GuideWell finals. Latest we have proven we can use our unique chemistry to pool many samples which could further reduce cost. Finally we signed a licensing agreement with Yale to move the test into saliva which enables self testing that reduces risk to healthcare providers and individuals as well. Using Telehealth we can provide access to COVID19 testing in remote underserved areas and provide testing without the need to travel.

 

This is our founder story: